CompletedNot Applicable

Urinary Tract Infection Due to Beta-lactamase-producing Enterobacteriaceae in Children

France590 participantsStarted 2014-03

Plain-language summary

Urinary tract infection due to Extended-spectrum beta-lactamase producing enterobacteriaceae (E-ESBL UTI) become a frequent problem. A too large variety in the prescription of antibiotics for E-ESBL UTI in children and absolute recommendations regarding the optimal treatment of E-ESBL is nearly impossible at this time. Our aim was to describe the characteristics and treatments of urinary tract infections caused by Extended spectrum betalactamase-producing Enterobacteriaceae in children.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All inpatient or outpatient under 18 years with UTI (cystitis or febrile UTI) * Clinical signs associated with a positive E-ESBL in urine culture dependent urine collection method as previously described (Stein R, EAU/ESPU guidelines) and an antibiotic treatment targeting this strain. Exclusion Criteria: * Refusal to participate in the study * Children with mixed microbial strains and repeated infections were excluded

What they're measuring

First and second lines used antibiotic therapies

Timeframe: at inclusion, at 3 days

Trial details

NCT IDNCT02832258

SponsorFouad Madhi

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-03-27

View on ClinicalTrials.gov More Urinary Tract Infections trials